Hexyl Aminolevulinate–Guided Fluorescence Cystoscopy in the Diagnosis and Follow-up of Patients with Non–Muscle-invasive Bladder Cancer: A Critical Review of the Current LiteratureMichael Rink, J. Alfred Witjes, Marko Babjuk et al.|European Urology|2013Cited by 240
Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”Marc‐Oliver Grimm, Luis Martínez‐Piñeiro, Marko Babjuk et al.|European Urology|2020Cited by 132
Photodynamic Therapy of Bladder Cancer – A Phase I Study Using Hexaminolevulinate (HAL)Markus Bader, Raphaela Waidelich, Herbert Stepp et al.|Urologic Oncology Seminars and Original Investigations|2012Cited by 92
Chromosome 9 deletions are more frequent than <i>FGFR3</i> mutations in flat urothelial hyperplasias of the bladderJohanna M.M. van Oers, Arndt Hartmann, C. Adam et al.|International Journal of Cancer|2006Cited by 90
FGFR3 mutation analysis in flat urothelial hyperplasia - strong evidence for chromosome 9 deletions as the earliest genetic alterations in the development of papillary bladder cancerRobert Stoehr, Arndt Hartmann, Johanna van Oers et al.|Cancer Research|2006Cited by 3